Survival advantage of using autologous blood transfusion during surgery for esophageal cancer

Surgery Today

Volumn 32, Issue 11, 2002, Pages 951-958

  Motoyama, Satoru ^a   Saito, Reijiro ^a   Kamata, Shuichi ^a   Kitamura, Michihiko ^a   Okuyama, Manabu ^a   Imano, Hiroshi ^a   Nakamura, Masakatsu ^a   Suzuki, Hiroyuki ^a   Omokawa, Susumu ^a   Motohashi, Yutaka ^a   Ogawa, Jun Ichi ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Autologous blood transfusion; Esophageal cancer; Survival

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD AUTOTRANSFUSION; CONTROLLED STUDY; DEATH; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HUMAN; INTRAOPERATIVE PERIOD; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATHOLOGY; PERIOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SURGICAL TECHNIQUE; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; BLOOD TRANSFUSION; BLOOD TRANSFUSION, AUTOLOGOUS; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0036451680     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005950200191     Document Type: Article

References (23)

1. Landers DF, Hill GE, Wong KC, Fox IJ. Blood transfusion-induced immunomodulation. Anesth Analg 1996;82:187-204.
2. Blajchman MA, Bardossy L, Carmen R, Sastry A, Singal DP. Allogeneic blood transfusion-induced enhancement of tumor growth: Two animal models showing amelioration by leuko-depletion and passive transfer using spleen cells. Blood 1993;81: 344-8.
3. Chung M, Steinmetz OK, Gordon PH. Perioperative blood transfusion and outcome after resection for colorectal carcinoma. Br J Surg 1993;80:427-32.
4. Vamvakas E, Moore SB. Perioperative blood transfusion and colorectal cancer recurrence: A qualitative statistical overview and meta-analysis. Transfusion 1993;33:754-65.
5. Shirwadkar S, Blajchman MA, Frame B, Singal DP. Effect of allogeneic blood transfusion on solid tumor growth and pulmonary metastases in mice. J Cancer Res Clin Oncol 1992;118:176-80.
6. Tartter PI. The association of perioperative blood transfusion with colorectal cancer recurrence. Ann Surg 1992;216:633-8.
7. Fong Y, Karpeh M, Mayer K, Brennan MF. Association of perioperative transfusions with poor outcome in resection of gastric adenocarcinoma. Am J Surg 1994;167:256-60.
8. Yamamoto J, Kosuge T, Takayama T, Shimada K, Yamasaki S, Ozaki H, et al. Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy. Surgery 1994;115:303-9.
9. Swisher SG, Holmes EC, Hunt KK, Gornbein JA, Zinner MJ, McFadden DW. Perioperative blood transfusions and decreased long-term survival in esophageal cancer. J Thorac Cardiovasc Surg 1996;112:341-8.
10. Craig SR, Adam DJ, Yap PL, Leaver HA, Elton RA, Cameron EW, et al. Effect of blood transfusion on survival after esophagogastrectomy for carcinoma. Ann Thorac Surg 1998;66: 356-61.
11. Tachibana M, Tabara H, Kotoh T, Kinugasa S, Dhar DK, Hishikawa Y, et al. Prognostic significance of perioperative blood transfusions in resectable thoracic esophageal cancer. Am J Gastroenterol 1999;94:757-65.
12. Heiss MM, Mempel W, Delanoff C, Jauch KW, Gabka C, Mempel M, et al. Blood transfusion-modulated tumor recurrence: First results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery. J Clin Oncol 1994;12:1859-67.
13. Busch OR, Hop WC, Hoynck van Papendrecht MA, Marquet RL, Jeekel J. Blood transfusions and prognosis in colorectal cancer. N Engl J Med 1993;328:1372-6.
14. Busch OR, Hop WC, Marquet RL, Jeekel J. Blood transfusions and local tumor recurrence in colorectal cancer. Ann Surg 1994;220:791-7.
15. Tashiro T, Yamamori H, Takagi K, Hayashi N, Furukawa K, Nitta H, et al. Changes in immune function following surgery for esophageal carcinoma. Nutrition 1999;15:760-6.
16. Salo M. Effects of anesthesia and surgery on the immune response. Acta Anaesthesiol Scand 1992;36:201-20.
17. Cole WH, Humphrey L. Need for immunologic stimulators during immunosuppression produced by major cancer surgeyr. Ann Surg 1985;202:9-20.
18. Abo S, Kitamura M, Hashimoto M, Izumi K, Minamiya Y, Shikama T, et al. Analysis of results of surgery performed over a 20-year period on 500 patients with cancer of the thoracic esophagus. Surg Today 1996;26:77-82.
19. Marquet RL, Hoynck van Papendrecht MA, Busch OR, Jeekel J. Blood donation leads to a decrease in natural killer cell activity: A study in normal blood donors and cancer patients. Transfusion 1993;33:368-73.
20. Bordin JO, Heddle NM, Blajchman MA. Biologic effects of leukocytes present in transfused cellular blood products. Blood 1994;84:1703-21.
21. Gafter U, Kalechman Y, Sredni B. Induction of a subpopulation of suppressor cells by a single blood transfusion. Kidney Int 1992;41:143-8.
22. Nielsen HJ. Detrimental effects of perioperative blood transfusion. Br J Surg 1995;82:582-7.
23. Lapierre V, Auperin A, Tiberghien P. Transfusion-induced immunomodulation following cancer surgery: Fact or fiction? J Natl Cancer Inst 1998;90:573-80.